SCHEMBL5552783

SCHEMBL5552783

CCCCCCCCO[Si](Cl)(OCCCCCCCC)OCCCCCCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.42
THRB P10828 2/20 0.42
RECQL P46063 2/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
EPHX2 P34913 1/20 0.41
BLM P54132 1/20 0.41
GBA1 P04062 1/20 0.41
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
LPAR3 Q9UBY5 5/20 0.38
CA1 P00915 5/20 0.38
CA2 P00918 5/20 0.38
CA9 Q16790 5/20 0.38
LPAR2 Q9HBW0 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5029850 1.00 TSHR (0.42) TSHRTHRBRECQLGLAHPGD
SCHEMBL5029810 1.00 TSHR (0.42) TSHRTHRBRECQLGLAHPGD
SCHEMBL5034233 1.00 TSHR (0.42) TSHRTHRBRECQLGLAHPGD
SCHEMBL5029783 1.00 TSHR (0.42) TSHRTHRBRECQLGLAHPGD
SCHEMBL5032207 0.97 TSHR (0.38) TSHRTHRBRECQLGLAHPGD
SCHEMBL15902030 0.93 TSHR (0.38) TSHRTHRBRECQLGLAHPGD
SCHEMBL613643 0.89 ADRB2 (0.41) TSHRTHRBRECQLGLAHPGD
SCHEMBL31065810 0.88 TSHR (0.38) TSHRTHRBRECQLGLAHPGD
SCHEMBL9230571 0.84 ADRB2 (0.38) TSHRALDH1A1TDP1CA1CA2
SCHEMBL9078326 0.84 THRB (0.42) TSHRTHRBMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9375484-B2 Taxane silicate prodrugs and nanoparticles REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2016-06-28 US disclosed
US-20140213550-A1 SILICATE PRODRUGS AND NANOPARTICLES REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2014-07-31 US disclosed
WO-2012166949-A1 SILICATE PRODRUGS AND NANOPARTICLES REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2012-12-06 WO disclosed
US-20070213204-A1 Ziegler-Natta catalyst with in situ-generated donor NOVOLEN TECHNOLOGY HOLDINGS C.V. 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213550-A1 SILICATE PRODRUGS AND NANOPARTICLES CASP3, S1PR3, SLCO1B3 TSHR 3141/4885THRB 3409/4885RECQL 2391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.